Lactobacillus acidophilus does not have any potential for health risks, MFDS says

Published: 2013-08-12 06:58:00

Updated: 2013-08-12 06:58:00

The state-run drug regulator on Thursday recalled all stocks of anti-diarrheal medicine Lacteol (tyndalized lactobacillus acidophilus) and its generic versions and suspended their sales until it completes an evaluation, citing that the efficacy of lactobacillus acidophilus in acute diarrhea has b...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK